Monday - March 02, 2026

Category Archives: Services

Vasculitis Clinical Trials Analysis 2026: Competitive Landscape, Regulatory Updates, Emerging Therapies, Mechanisms of Action, and Routes of Administration | DelveInsight

Vasculitis Pipeline Leading companies involved in the Vasculitis therapeutic space include R-Pharm Overseas, AbbVie, Toleranzia, Ambulero, Visterra, CytoDyn, ChemoCentryx, Hoffmann-La Roche, GlaxoSmithKline, Vifor Pharma, Beijing Defengrei Biotechnology, InflaRx, Janssen Biotech, Novartis, Oxitope Pharma, Eli Lilly and Company, Travere Therapeutics, Caladrius … Continue reading →

Diagnostic Imaging Equipment Market to Reach USD 82.26 Billion by 2034, Growing at 5.39% CAGR from 2026-2034 Amid Rising Chronic Disease Burden and AI-Driven Innovation, analyses DelveInsight

Diagnostic Imaging Equipment Market The global diagnostic imaging equipment market is projected to grow from USD 51,560.07 million in 2025. Also, Market growth is largely attributed to the increasing burden of chronic illnesses such as cardiovascular diseases, cancer, neurological disorders, … Continue reading →

Orforglipron Market Set for Transformational Growth Across Obesity and Type 2 Diabetes Landscape Through 2034 | DelveInsight

Orforglipron Market Global momentum builds around investigational oral GLP-1 receptor agonist Orforglipron as Phase III data signal strong commercial and clinical potential The global metabolic disorder treatment landscape is on the brink of significant transformation as Orforglipron, an investigational once-daily … Continue reading →

Melanoma Treatment Pipeline Shows Strong Momentum as 150+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Melanoma Pipeline Insights 2026” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in the Melanoma Pipeline landscape. It covers the Melanoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Melanoma pipeline … Continue reading →

Major Depressive Disorder Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Lou Gehrig’s Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Lou Gehrig’s disease Pipeline Insight, 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the Lou Gehrig’s disease pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Liver Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Liver Cancer Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Influenza Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Influenza Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Influenza pipeline landscape. It covers the Influenza Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Influenza Pipeline … Continue reading →